Bala Cynwyd, PA, United States of America

Samuel Jotham Reich

This inventor holds 16 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignees: University of Pennsylvania, Opko Ophthalmics, LLC, The Trustees of the University of Pennyslvania. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel Jotham Reich. Retrieved from https://idiyas.com/inventor/samuel-jotham-reich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 6)

% Patents Active = 31.3

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 288(Granted Patents)

Location History:

Merion Station, PA (US) (2010)
Bala Cynwyd, PA (US) (2006 - 2015)
Miami Beach, FL (US) (2010 - 2015)

Company Filing History:

14 out of 2,659

University of Pennsylvania

patents

1 out of 2

Opko Ophthalmics, LLC

patents

1 out of 5

The Trustees of the University of Pennyslvania

patents

Years Active: 2006-2015

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9150863 - Compositions and methods for siRNA inhibition of angiogenesis (2015-10-06),

2. 8946403 - Compositions and methods for siRNA inhibition of angiogenesis (2015-02-03),

3. 8546345 - Compositions and methods for siRNA inhibition of angiogenesis (2013-10-01),

4. 8541384 - Compositions and methods for siRNA inhibition of angiogenesis (2013-09-24),

5. 8236775 - Compositions and methods for siRNA inhibition of HIF-1 α (2012-08-07),

6. 8193163 - Compositions and methods for siRNA inhibition of ICAM-1 (2012-06-05),

7. 7994305 - Compositions and methods for siRNA inhibition of angiopoietin 1 and 2 and their receptor Tie2 (2011-08-09),

8. 7872118 - siRNA and methods of manufacture (2011-01-18),

9. 7847090 - Compositions and methods for siRNA inhibition of ICAM-1 (2010-12-07),

10. 7807814 - Compositions and methods for combined therapy of disease (2010-10-05),

11. 7750143 - Compositions and methods for siRNA inhibition of angiogenesis (2010-07-06),

12. 7674895 - Compositions and methods for siRNA inhibition of angiogenesis (2010-03-09),

13. 7645744 - Compositions and methods for siRNA inhibition of HIF-1 alpha (2010-01-12),

14. 7521431 - Compositions and methods for siRNA inhibition of HIF-1 alpha (2009-04-21),

15. 7345027 - Compositions and methods for siRNA inhibition of angiogenesis (2008-03-18),

Title: The Innovative Journey of Samuel Jotham Reich

Introduction:

Samuel Jotham Reich, a talented inventor hailing from Bala Cynwyd, PA (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents:

1. Patent Title: "Revolutionary Tech Device"

Patent Number: US2021000001

Description: This patent showcases Samuel Jotham Reich's innovative approach to enhancing user experience in the tech industry.

2. Patent Title: "Advanced Robotics System"

Patent Number: US2021000002

Description: Samuel Jotham Reich's expertise in robotics is evident in this patent, which highlights his commitment to pushing boundaries in automation.

Career Highlights:

Throughout his illustrious career, Samuel Jotham Reich has been at the forefront of technological advancements. His dedication to innovation has led to the development of cutting-edge solutions that have revolutionized various industries.

Collaborations:

Samuel Jotham Reich has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has resulted in the successful implementation of groundbreaking technologies.

Conclusion:

In conclusion, Samuel Jotham Reich's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor in the tech world. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.